INS and metabolic dysfunction-associated steatohepatitis: In contrast, the NASH treatment caused a frank hyperinsulinemic state as compared to the control group (plasma insulin values of 5.56 ± 1.09 and 3.26 ± 0.31 ηg/mL, resp; Figure 1(b), P < 0.05).